Answer
Rocuronium bromide produces non-depolarizing neuromuscular blockade by competing for nicotinic cholinoceptors at the motor end-plate, an action antagonised by acetylcholinesterase inhibitors such as neostigmine, edrophonium and pyridostigmine.
Sources for this answer
- Rocuronium 10 mg/ml solution for injection / infusionhameln pharma ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 13Document updated
Sources checked